Simplex Trading’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Simplex Trading’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,700	Closed	-$127K	–	11441
2022 Q2	$127K	Buy	1,700 +1,500	+750%	+$66.7K	﹤0.01%	5244
2022 Q1	$5K	Hold	200	–	–	﹤0.01%	9499
2021 Q4	$9K	Buy	+200	New	+$8.94K	﹤0.01%	9165
2021 Q2	–	Sell	-2	Closed	-$18K	–	10973
2021 Q1	$18K	Sell	2 -1	-33%	-$119	﹤0.01%	7562
2020 Q4	$36K	Buy	+3	New	+$329	﹤0.01%	6515
2020 Q2	–	Sell	-2	Closed	-$8K	–	8657
2020 Q1	$8K	Buy	+2	New	+$106	﹤0.01%	6635

Simplex Trading's TPTX Position: Q3 2022 in Review

Simplex Trading sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 1,818 shares — an estimated $136K sold.

Simplex Trading first reported a position in TPTX in Q2 2021 and held it in 5 quarters. The position peaked at $167K in Q4 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Simplex Trading reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 1,818 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $136K.
Simplex Trading first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Simplex Trading's Turning Point Therapeutics, Inc. Common Stock position peaked at $167K in Q4 2021.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.